| Literature DB >> 25584149 |
Abstract
Saururus chinensis has been reported to contain compounds such as lignans, alkaloids, diterpenes, flavonoids, tannins, steroids, and lipids. Fermentation is commonly used to break down certain undesirable compounds, to induce effective microbial conversion, and to improve the potential nutraceutical values. Previous studies have reported that the fermentation process could modify naturally occurring constituents, including isoflavons, saponins, phytosterols, and phenols, and could enhance biological activities, specifically antioxidant and antimicrobial properties. The probiotic strains used for fermentation exert beneficial effects and are safe. In this study, the antioxidative effects of the Bacillus subtilis fermentation of Saururus chinensis were investigated in a rat model with Triton WR-1339-induced hyperlipidemia by comparing the measured antioxidative biological parameters of fermented Saururus chinensis extract to those of nonfermented Saururus chinensis extract. Fermentation played a more excellent role than nonfermentation in ultimately protecting the body from oxidative stress in the liver of the experimental rats with Triton WR-1339-induced hyperlipidemia.Entities:
Keywords: Fermentation; Hyperlipidemia; Oxidative stress; Saururus chinensis
Year: 2014 PMID: 25584149 PMCID: PMC4289930 DOI: 10.5487/TR.2014.30.4.291
Source DB: PubMed Journal: Toxicol Res ISSN: 1976-8257
Experimental design of the hyperlipidemic rats
| Experimental group (n) | Day 1~20 treatment (dose) | Day 21 treatment (dose) |
|---|---|---|
|
| ||
| NOR (7) | 1.5 ml/kg 0.9% saline, i.p. | 0.9% saline (1.5 ml/kg, i.p.) |
| TWR (7) | 1.5 ml/kg 0.9% saline, i.p. | Triton WR-1339 (200 mg/kg, through tail vein) |
| FSCT (7) | 1.5 ml/kg FSC extract (5 mg/kg), i.p. | |
| NFSCT (7) | 1.5 ml/kg NFSC extract (5 mg/kg), i.p. | |
NOR: normal group; TWR: Triton WR-1339-treated group; FSCT: fermented Saururus chinensis extract and Triton WR-1339-treated group; NFSCT: nonfermented Saururus chinensis extract and Triton WR-1339-treated group; i.p.: intraperitoneally; n: number of animals.
Fig. 1.Cell Growth of Bacillus subtilis 168 in temperature condition FSC-40: fermented Saururus chinensis extract-40℃. FSC-30: fermented Saururus chinensis extract-30℃. This was for the confirmation of optimal fermentation temperature, which was 40℃.
Fig. 2.Free radical scavenging effect in FSC and NFSC at 40℃. FSC: fermented Saururus chinensis extract; NFSC: nonfermented Saururus chinensis extract. This was for the confirmation of optimal fermentation time, which was 34 hr.
SOD, CAT, GPx levels in liver total homogenate and mitochondrial fraction of Triton WR-1339-induced hyperlipidemic rats
| Experimental group | NOR (unit/mg protein) | TWR (unit/mg protein) | FSCT (unit/mg protein) | NFSCT (unit/mg protein) | |
|---|---|---|---|---|---|
|
| |||||
| MF | SOD | 57.93 ± 3.09c | 31.02 ± 0.59a | 53.95 ± 1.09c (85.21) | 46.36 ± 2.95b (57.02) |
| LH | SOD | 50.18 ± 4.78d | 15.57 ± 1.35a | 42.02 ± 0.61c (76.42) | 35.53 ± 0.61b (57.65) |
| CAT | 276.72 ± 13.54d | 52.28 ± 5.20a | 128.93 ± 10.97c (34.15) | 101.62 ± 11.93b (21.98) | |
| GPx | 91.00 ± 4.09d | 27.13 ± 9.79a | 64.27 ± 4.95c (58.15) | 53.04 ± 7.71b (40.56) | |
NOR: normal group, TWR: Triton WR-1339-induced group, FSCT: fermented Saururus chinensis extract and Triton WR-1339-treated group, NFSCT: nonfermented Saururus chinensis extract and Triton WR-1339-treated group, MF: mitochondrial fraction (unit/mg protein), LH: liver total homogenates (unit/mg protein), SOD: superoxide dismutase, CAT: catalase, GPx: glutathione peroxidase.
The number of pqrenthesis is the rate of inhibition(%).
Results are presented as the mean ± S.D. (n = 7).
a, b, c, d are different group by one-way ANOVA with post-hoc test.
Fig. 4.Presentation of significant differences for SOD, CAT, GPx levels in liver total homogenate NOR: normal group; TWR: Triton WR-1339-treated group; FSCT: fermented Saururus chinensis extract and Triton WR-1339-treated groups; NFSCT: nonfermented Saururus chinensis extract and Triton WR-1339-treated group. MF: mitochondrial fraction; LF: liver total homogenate fraction. The results are presented as mean ± SD (n = 7). Significantly different from the value of the TWR group at ***p< 0.001 and *p<0.01.
MDA levels in liver total homogenate of Triton WR-1339-induced hyperlipidemic rats
| Liver total homogenate | ||
|---|---|---|
|
| ||
| Experimental group | MDA contents (nmol/mg protein) | Inhibition (%) |
|
| ||
| NOR | 1.14 ± 0.24a | - |
| TWR | 4.24 ± 0.17d | - |
| FSCT | 1.90 ± 0.19b | 75.42 |
| NFSCT | 2.72 ± 0.13c | 48.98 |
NOR: normal group, TWR: Triton WR-1339-treated group, FSCT: fermented Saururus chinensis extract and Triton WR-1339-treated group, NFSCT: nonfermented Saururus chinensis extract and Triton WR-1339-treated group, MDA: malondialdehyde.
Results are presented as the mean ± S.D. (n = 7).
a, b, c, d are different group by one-way ANOVA with post-hoc test.
Fig. 3.Histological examination of liver tissue (H&E staining, 200x). (A) NOR: normal group (B) TWR: Triton WR-1339-treated group (C) FSCT: fermented Saururus chinensis extract and Triton WR-1339-treated group (D) NFSCT: nonfermented Saururus chinensis extract and Triton WR-1339-treated group; original magnification: 200x; H&E: hematoxylin and eosin.